"Nephrology & Hypertension Associates is a specialty practice managing your Nephrology and Hypertension needs. We are committed to providing the best care available."

During the past decade, Nephrology and Hypertension Associates, LTD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nephrology and Hypertension Associates, LTD" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 2 trials, followed by "Ardelyx" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Christopher Granger, MD" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrology and Hypertension Associates, LTD" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nephrology and Hypertension Associates, LTD" are "Glomerulosclerosis, Focal Segmental" (2 trials), "Kidney Diseases" (2 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Nephrology and Hypertension Associates, LTD" in a lesser frequency.

Most popular intervention types in "Nephrology and Hypertension Associates, LTD" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "VX-147" (2 trials), "GFB-887" (1 trials), "Phosphate Binder Agents" (1 trials) and "Renal Autologous Cell Therapy (REACT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nephrology and Hypertension Associates, LTD" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nephrology and Hypertension Associates, LTD". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nephrology and Hypertension Associates, LTD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nephrology and Hypertension Associates, LTD, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".